A carregar...
Tumor refractoriness to anti-VEGF therapy
Vascular endothelial growth factor (VEGF) has been identified as the most potent cytokine involved in tumor angiogenesis and metastasis formation. Clinical results of anti-angiogenic therapies targeting VEGF and its receptors are very modest, resulting in a moderate improvement of overall survival....
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5216828/ https://ncbi.nlm.nih.gov/pubmed/27081695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8694 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|